1WHO. WHO Recommendations for the production,control and Regulation of human plasma for fractionation [ M ]. WHO Export committee on Biological scanddardization ,2005,48
2Finger S,Bellomo R,Boyce N,et al. A comparison of Albumin and Saline for Fluid Resuscitation in intensive care unit[ J]. N Engl J Med ,2004,350(22) :2247-2256
3Buehacher A ,Jberer G. Purification of intravenous imnmnoglobulin G from human plasma-aspects of yield and vires safety [ J ]. Biotechnol J ,2006,1 (2) : 148-163
4Bumouf T. Modem Plasma Fractionation [ J ]. Transfus Med Rev, 2007,21(2) :101-117
5Vo A,Jordan SC. MG Therapy:an Emerging Rde in Organ Transplantation[ J ]. Pharmacist,2004,29 ( 3 ) :20-25
3Hollingsworth B, Wildman J. What population factors influence the decision to donate blood.'? Transfusion medicine , 2004 ,14( 1 ) :9- 12.
4Zou S, Musavi F, Notari EPt, et al. Changing age distribution of the blood donor population in the United States. Transfusion ,2008 ,48(2) :251-257.
5Greinacher A, Fendrieh K, Alpen U, et al, Impact of demographic changes on the blood supply: Mecklenburg-Wet Pomerania as a model region for Europe. Transfusion,2007 ,47(3) :395-401.
6Veldhuizen IJ, Doggen CJ, Atsma F, et al. Donor profiles: demo- graphic factors and their influence on the donor career. Vox sang ,2009 ,97 (2) : 129-138.
7Edgren G, Tran TN, Hjalgrim H, et 8]. Improving health profile of blood donors asa consequence of transfusion safety efforts. Trans- fusion, 2007 ,47 ( 11 ) :2017-2024.
8Tuomainen TP, Punnonen K, Nyyssenen K, et al. Association be- tween body iron stores and the risk of acute myocardial infarction in men. Circulation , 1998 ,97 ( 15 ) : 1461-1466.
9Veldhuizen I, van Dongen A. Motivational differences between whole blood and plasma donors already exist before their first dona- tion experience. Transfusion ,2013 ,53 (8): 1678-1686.
